Your session is about to expire
← Back to Search
Procedure
Arthroscopic vs Open Surgery for Infectious Arthritis
N/A
Waitlist Available
Research Sponsored by Texas Tech University Health Sciences Center, El Paso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through anticipated follow up period of 3 month post operative appointment.
Awards & highlights
Study Summary
This trial found that arthroscopic management of septic arthritis in the native knee resulted in a lower number of surgeries and a shorter length of stay compared to open arthrotomy.
Eligible Conditions
- Septic Arthritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through anticipated follow up period of 3 month post operative appointment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through anticipated follow up period of 3 month post operative appointment.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hospital length of stay
Number of surgeries to obtain lasting clinical resolution
Secondary outcome measures
Lysholm Knee Scale
Post Operative Opioid Use
Post Operative Pain Scores
Trial Design
1Treatment groups
Experimental Treatment
Group I: Patients with confirmed septic arthritis of the native kneeExperimental Treatment2 Interventions
Find a Location
Who is running the clinical trial?
Texas Tech University Health Sciences Center, El PasoLead Sponsor
49 Previous Clinical Trials
5,110 Total Patients Enrolled
Adam Adler, MDStudy DirectorTexas Tech University Health Sciences Center of El Paso
2 Previous Clinical Trials
149 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Patients with confirmed septic arthritis of the native knee
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still room for more people in this experiment?
"From the information readily available on clinicaltrials.gov, it appears as though this study is looking for more participants. This trial was originally posted on April 1st 2021 and has been updated as recently as June 8th 2021."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger